Chin et al. reported an abundance of CREB3L3 in benign liver cells where it binds to CRE and ATF6 enhancer elements to promote transcription while preventing hepatocellular carcinoma (HCC) cells from entering S phase [127]. This evidence concerns the gene CREB3L3 and hepatocellular carcinoma.